Buy PB-22 Online


5F-PB-22, or quinolin-8-yl 1-pentyfluoro-1H-indole-3-8-carboxylate, is a synthetic Indole cannabinoid (page does not exist)” Indole_cannabinoid&amp as it contains a substituted core indole structure. This indole core is shared with other cannabinoid substances including “PB-22 (page does not exist)” PB-22″JWH-018″AM2201 (page does not exist)” 5F-PB-22 is an ether with formula R-O-R’, which can be understood as a substance with two sub-units joined through an oxygen bridge. The indole group of 5F-PB-22 is substituted at R5 with a fluoropentyl chain, a substitution shared with “5F-AKB48” 5F-AKB48″5F-AKB48. Additionally, the indole core is substituted at R3 with a carboxylic acid group. The terminal oxygen of this carboxylic acid is bonded through an ether bond to a quinoline group at location R8 of the heterocycle.


5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) is a synthetic cannabinoid receptor agonist (SCRA) that had no history in the scientific literature until its detection emerged
in 2013. This substance has been encountered as a synthetic constituent found in herbal smoking mixtures that are sold under a variety of brand names. It is common for retailers to purchase bulk
quantities of the synthetic substance and add the synthetic material to plant matter that is then distributed onto the market. However, 5F-PB-22 is also available in powdered form as a “research
chemical”. Various UN Member States reported the identification of 5F-PB-22 first in 2013 and data obtained from law enforcement suggest that 5F-PB-22 emerged and peaked in 2013 and 2014
in the United States of America, which then dropped in the following years.
A small number of in vitro and in vivo studies are currently available but the data indicate that 5FPB-22 binds to and activates human CB1 and CB2 receptors at low nanomolar concentrations, and
that it induces a number of biological responses also triggered by the naturally occurring phytocannabinoid Δ9-THC. In some in vitro assays, 5F-PB-22 acted as a full at both cannabinoid receptors. 5F-PB-22 also fully substituted for Δ9-THC in the drug discrimination paradigm and was ~22 times more potent than the training drug, which suggests that 5F-PB-22 may have abuse liability similar to Δ9-THC and/or other internationally controlled synthetic cannabinoid receptor agonists.Reports indicate an increasing trend for SCRAs being implicated in mini epidemics that have been associated with severe adverse drug effects including deaths. Reported adverse drug reactions associated with a range of SCRAs frequently include gastrointestinal (e.g. nausea/hyperemesis),neurological (e.g. hallucination, agitation, anxiety, paranoia, confusion, delusions, catatonia,
lethargy, psychosis (including susceptible individuals)), cardiovascular (e.g. tachycardia,hypertension) and renal (e.g. acute kidney failure) feature .


10 g, 100 g, 1000 g, 25 g, 250 g, 50 g, 500 g


There are no reviews yet.

Be the first to review “Buy PB-22 Online”

Your email address will not be published. Required fields are marked *